(Q31121298)

29 June 2017

1 reference

title

Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature (English)

1 reference

29 June 2017

Townsend KP

1

1 reference

29 June 2017

Obregon D

2

1 reference

29 June 2017

Quadros A

3

1 reference

29 June 2017

Patel N

4

1 reference

29 June 2017

Volmar Ch

5

1 reference

29 June 2017

Paris D

6

1 reference

29 June 2017

Mullan M

7

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Annals of the New York Academy of Sciences

29 June 2017

published in

1 reference

29 June 2017

volume

977

1 reference

29 June 2017

page(s)

65-76

1 reference

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Microvessels from Alzheimer's disease brains kill neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Amyloid beta-protein and the genetics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2002.TB04799.X

10.1111/J.1749-6632.2002.TB04799.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference